Mezzion Pharma Co.,Ltd. (KOSDAQ: 140410)
South Korea
· Delayed Price · Currency is KRW
31,300
+400 (1.29%)
Nov 15, 2024, 9:00 AM KST
Mezzion Pharma Co.,Ltd. Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Nov '24 Nov 14, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 925,867 | 1,153,908 | 347,646 | 1,932,235 | 1,563,338 | 1,665,449 | |
Market Cap Growth | 12.31% | 231.92% | -82.01% | 23.60% | -6.13% | 112.14% | |
Enterprise Value | 885,477 | 1,093,258 | 314,521 | 1,903,261 | 1,542,499 | 1,617,083 | |
Last Close Price | 30900.00 | 39000.00 | 13000.00 | 72366.67 | 58600.00 | 63766.67 | |
Forward PE | - | - | - | - | 151.06 | - | |
PS Ratio | 45.24 | 36.38 | 11.31 | 72.49 | 54.60 | 92.94 | |
PB Ratio | 16.73 | 18.78 | 13.25 | 30.77 | 27.52 | 38.89 | |
P/TBV Ratio | 20.68 | 19.29 | 14.12 | 31.59 | 28.33 | 40.41 | |
EV/Sales Ratio | 43.74 | 34.46 | 10.24 | 71.41 | 53.87 | 90.24 | |
EV/FCF Ratio | -69.26 | - | - | - | - | - | |
Debt / Equity Ratio | 0.01 | 0.01 | 0.04 | 0.07 | 0.09 | 0.08 | |
Asset Turnover | 0.24 | 0.43 | 0.45 | 0.33 | 0.43 | 0.27 | |
Inventory Turnover | 2.59 | 3.82 | 3.01 | 2.44 | 3.26 | 3.58 | |
Quick Ratio | 2.01 | 2.12 | 1.35 | 2.72 | 3.34 | 3.28 | |
Current Ratio | 2.65 | 2.51 | 1.76 | 3.47 | 3.91 | 3.84 | |
Return on Equity (ROE) | -14.54% | -29.03% | -81.54% | -22.75% | -27.85% | -46.53% | |
Return on Assets (ROA) | -11.45% | -12.39% | -21.14% | -13.16% | -7.00% | -22.85% | |
Return on Capital (ROIC) | -15.12% | -20.29% | -30.89% | -16.27% | -8.69% | -29.43% | |
Earnings Yield | -0.97% | -1.10% | -10.44% | -0.70% | -0.88% | -1.40% | |
FCF Yield | -1.38% | -1.00% | -3.69% | -0.80% | -0.52% | -1.32% | |
Buyback Yield / Dilution | -10.53% | -5.63% | -0.17% | -2.63% | -0.11% | -4.24% | |
Total Shareholder Return | -10.53% | -5.63% | -0.17% | -2.63% | -0.11% | -4.24% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.